Journal article

Current and emerging therapies for coeliac disease

Laura Kivela, Alberto Caminero, Daniel A Leffler, Maria Ines Pinto-Sanchez, Jason A Tye-Din, Katri Lindfors

Nature Reviews Gastroenterology & Hepatology | NATURE RESEARCH | Published : 2020


Coeliac disease is a common enteropathy that occurs in genetically susceptible individuals in response to the ingestion of gluten proteins present in wheat, rye and barley. Currently, the only available treatment for the condition is a strict, life-long gluten-free diet that, despite being safe and often effective, is associated with several challenges. Due to the high cost, particularly restrictive nature and perception of decreased quality of life associated with the diet, some patients are continuously exposed to gluten, which prevents an adequate disease control. Moreover, a subgroup of patients does not respond to the diet adequately, and healing of the small-bowel mucosa can be incompl..

View full abstract

University of Melbourne Researchers


Awarded by National Health and Medical Research Council of Australia (NHMRC)

Funding Acknowledgements

The authors thank the Academy of Finland and the Sigrid Juselius Foundation (K.L.), Emil Aaltonen foundation and the Finnish-Norwegian Medical Foundation (L.K.), the National Health and Medical Research Council of Australia (NHMRC, Investigator Grant APP1176553), and the Mathison Centenary Fellowship, University of Melbourne (J.T.-D.). A.C. holds a Paul Douglas chair in intestinal research.